Gastrointesinal stromal tumor: Analysis of factors related to the prognostic;Tumor estromal gastrointestinal: Análise de fatores relacionados ao prognóstico

Revista do Colegio Brasileiro de Cirurgioes

Volumn 34, Issue 6, 2007, Pages 374-380

  de Oliveira, Rodrigo Panno Basilio ^a,b,e   Pannain, Vera Lucia ^b   Portari Filho, Pedro Eder ^a   Salomão, Alemar Roge ^c   Iglesias, Antonio Carlos ^a,d   Oliveira, Carlos Alberto Basilio ^b,d  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Instituto Nacional do Câncer INCA I

^d HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^e NONE   (Brazil)

Author keywords

Gastrointestinal neoplasms; Gastrointestinal Stromal Tumors; Immunohistochemistry; Morphology; Prognosis; Stromal Cells

Indexed keywords

EID: 39449121376     PISSN: 01006991     EISSN: 18094546     Source Type: Journal    
DOI: 10.1590/s0100-69912007000600004     Document Type: Article

References (39)

1. Shinomura Y, Kinoshita K, Tsutsui S, Hirota S. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors. J Gastroenterol. 2005;40(8):775-80.
2. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term followup. Am J Surg Pathol. 2005;29(1):52-68.
3. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577-80.
4. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708-10. Epub 2003 Jan 9.
5. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259-69.
6. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumor. J Clin Oncol. 2004;22(18):3813-25.
7. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol. 1999;30(10):1213-20.
8. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70-83.
9. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005;100(1):162-8.
10. Ferchichi L, Kourda N, Zermani R, Aouem J, Zaouche A, Abdjellil Z, Najah N, Baltagi Ben Jilani S. Les tumeurs stromales extradigestives: à propos de quatre observations. Ann Chir. 2006;131(4):271-5. Epub 2005 Oct 17.
11. Park SS, Min BW, Kim WB, Choi JW, Lee JH, Chae YS, Um JW, Mok YJ, Moon HY. Malignant extragastrointestinal stromal tumor of retroperitoneum. Acta Oncol. 2005;44(5):497-9.
12. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002;33(5):459-65.
13. Rossi CR, Mocellin S, Mencarelli R, Foletto M, Pilati P, Nitti D, Lise M. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer. 2003; 107(2):171-6.
14. Efton DT, Lillemoe KD. Current management of gastrointestinal stromal tumors. Adv Surg. 2005;39:193-221.
15. Gold JS, DeMatteo RP. Combined surgical and molecular therapy. The gastrointestinal stromal tumor model. Ann Surg. 2006;244(2):176-84.
16. Gupta M, Sheppard BC, Corless CL, MacDonell KR, Blanke CD, Billingsley KG. Outcome following surgical therapy for gastrointestinal stromal tumor. J Gastrointest Surg. 2006;10(8):1099-105.
17. Gutierrez JC, De Oliveira LOP, Perez EA, Rocha-Lima C, Livingstone AS, Koniaris LG. Optimizing diagnosis, staging, and management of gastrointestinal stromal tumor. J Am Coll Surg. 2007;205(3):479-91 (Quiz 524). Epub 2007 Jul 16.
18. Valadão M, Lourenço LG, Linhares E, Romano S, Kesley R, Siqueira D. Fatores prognósticos clínicos e anatomopatológicos dos tumores estromais gastrointestinais (GIST) de origem gástrica. Rev Col Bras Cir. 2006;33(5):298-304.
19. Hinz S, Pauser U, Egberts JH, Schafmayer C, Tepel J, Fändrich F. Audit of a series of 40 gastrointestinal stromal tumor cases. Eur J Surg Oncol. 2006;32(10):1125-29. Epub 2006 Jul 20.
20. Hsu K-H, Yang T-M, Shan Y-S, Lin P-W. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor. Am J Surg. 2007;194(2):148-52.
21. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438(1):1-12.
22. Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol. 2007;23(2):149-58.
23. Evans HL. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer. 1985;56(9):2242-50.
24. Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, Bonvalot S. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol. 2004;30(10):1098-103.
25. Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol. 2005;36(7):828-37. Erratum in: Hum Pathol. 2006;37(4):503.
26. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer. 2005;103(4):821-9.
27. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51-8.
28. Yan H, Marchettini P, Acherman YI, Gething SA, Brun E, Sugarbaker PH. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol. 2003;26(3):221-8.
29. Ricci R, Arena V, Castri F, Martini M, Maggiano N, Murazio M, Pacelli F, Potenza AE, Vecchio FM, Larocca LM. Role of p16/INK4a in gastrointestinal stromal tumor progression. Am J Clin Pathol. 2004;122(1):35-43.
30. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer. 2003;6(1):39-48.
31. Wong NA, Young R, Malcomson RD, Nayar AG, Jamieson LA, Save VE, Carey FA, Brewster DH, Han C,. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 2003;43(2):118-26.
32. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 2002;33(6):669-76.
33. Ozgüç H, Yilmazlar T, Yerci O, Soylu R, Tümay V, Filiz G, Zorluoglu A. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg. 2005;9(3):418-29.
34. Bucher P, Taylor S, Villiger P, Morel P, Brundler MA. Are there any prognostic factors for small intestinal stromal tumors? Am J Surg. 2004; 187(6):761-6.
35. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477-89.
36. Miettinen M, El-Rifai W, Sobin LH, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33(5):478-83.
37. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13(10):1134-42.
38. Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002;20(18):3898-905.
39. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002;33(5):466-77.